<DOC>
	<DOCNO>NCT01160627</DOCNO>
	<brief_summary>OBJECTIVE : To evaluate efficacy prevention contrast induce nephropathy patient ST segment elevation myocardial infarction treat primary percutaneous coronary intervention . DESIGN : Prospective study . SETTING : Three-center study Acute kidney injury define rise creatinine &gt; 25 % baseline Serum creatinine measure baseline day follow 3 day 30 day . Patients randomise : 1 . Standard treatment 2 . Standard treatment + acetylcystein 2 day 3 . Standard treatment + Sodium bicarbonate 500 ml / follow 100 ml/h 5 hour 4 . Standard treatment + acetylcystein 2 day + Sodium bicarbonate 500 ml / follow 100 ml/h 5 hour</brief_summary>
	<brief_title>Prevention Contrast-induced Nephropathy Patients With Acute Myocardial Infarction</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>STEMI patient treat primary PCI Cardiogenic shock</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>CIN STEMI</keyword>
</DOC>